Share

February 10, 2015; 84 (6) Article

“Noncognitive” symptoms of early Alzheimer disease

A longitudinal analysis

Mary Clare Masters, John C. Morris, Catherine M. Roe
First published January 14, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001238
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1119

Share

Article Information

vol. 84 no. 6 617-622
DOI: 
https://doi.org/10.1212/WNL.0000000000001238
PubMed: 
25589671
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received June 16, 2014
  • Accepted in final form October 10, 2014
  • First Published January 14, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Mary Clare Masters, MD,
    2. John C. Morris, MD and
    3. Catherine M. Roe, PhD
  1. Mary Clare Masters, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. John C. Morris, MD and
    3. Scientific Advisory Boards:

    1. Lilly USA

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Serves on the editorial advisory board of JAMA Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. 1. Blackwell Publishing, 2009, for Burns J and Morris JC, “Mild Cognitive Impairment and Early Alzheimer's Disease”, copyright 2008 by John Wiley and Sons, Ltd 2. Taylor & Francis 2008; “Handbook of Dementing Illnesses, 2 Ed”, Morris JC, Galvin JE, Holtzman DM, Eds, copyright 2006

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Receives research support from Eli Lilly/Avid Radiopharmaceuticals

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Catherine M. Roe, PhD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Salary support from NIH/NIA (R01 AG04343401, R01 AG15928- 02, P50-AG05681, P50-AG0568129 and P01- AG03991), the Longer Life Foundation, from the Charles and Joanne Knight Alzheimer Research Initiative of the Knight Alzheimer?s Disease Research Center, The Farrell Family Research Fund, and The generous support of F Simmons and O Mohan.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Salary support from NIH/NIA (R01 AG04343401, R01 AG15928- 02, P50-AG05681, P50-AG0568129 and P01- AG03991),

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. The Charles and Joanne Knight Alzheimer Research Initiative of the Knight Alzheimer?s Disease Research Center, the Longer Life Foundation, The Farrell Family Research Fund, and The generous support of F Simmons and O Mohan

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (J.C.M., C.M.R.), Pathology and Immunology (J.C.M.), Physical Therapy (J.C.M.), and Occupational Therapy (J.C.M.), and Knight Alzheimer's Disease Research Center (J.C.M., C.M.R.), Washington University School of Medicine (M.C.M., J.C.M., C.M.R.), St. Louis, MO.
  1. Correspondence to Dr. Roe: cathyr{at}wustl.edu
View Full Text

Article usage

Article usage: January 2015 to August 2021

AbstractFullPdfSource
Jan 201548620148Highwire
Feb 2015385147135Highwire
Mar 20151291336147Highwire
Apr 201510211625Highwire
May 20154351323Highwire
Jun 2015321913Highwire
Jul 2015246812Highwire
Aug 20152481113Highwire
Sep 201524586Highwire
Oct 201524085Highwire
Nov 201525077Highwire
Dec 201523344Highwire
Jan 201613422Highwire
Feb 20169023Highwire
Feb 20160209pmc
Mar 201611154Highwire
Mar 201602317pmc
Apr 201611822Highwire
Apr 201603122pmc
May 201612933Highwire
May 201602616pmc
Jun 201611537Highwire
Jun 20160118pmc
Jul 201616523Highwire
Jul 201602719pmc
Aug 20169213Highwire
Aug 201601811pmc
Sep 201610111Highwire
Sep 201601812pmc
Oct 20169614Highwire
Oct 2016095pmc
Nov 20169351Highwire
Nov 20160164pmc
Dec 20166512Highwire
Dec 201602012pmc
Jan 20178011Highwire
Jan 20170207pmc
Feb 20179243Highwire
Feb 201701811pmc
Mar 20178228Highwire
Mar 201702817pmc
Apr 20178024Highwire
Apr 2017182627pmc
May 20178510Highwire
May 201791622pmc
Jun 20176211Highwire
Jun 2017121915pmc
Jul 20175711Highwire
Jul 201741414pmc
Aug 20175311Highwire
Aug 201761110pmc
Sep 20174600Highwire
Sep 201781921pmc
Oct 201711012Highwire
Oct 201791718pmc
Nov 201710518Highwire
Nov 2017112931pmc
Dec 201740612Highwire
Jan 201823713Highwire
Feb 201813350Highwire
Mar 201819153Highwire
Apr 201816910Highwire
Apr 201862331pmc
May 201831342Highwire
Jun 201829933Highwire
Jun 201883239pmc
Jul 201823715Highwire
Aug 201817743Highwire
Aug 2018164345pmc
Sep 201814713Highwire
Oct 201818812Highwire
Nov 201814321Highwire
Dec 201815200Highwire
Jan 201912610Highwire
Feb 201912931Highwire
Mar 201911863Highwire
Apr 20197811Highwire
May 201910350Highwire
Jun 20198421Highwire
Jul 20195613Highwire
Aug 20196001Highwire
Sep 20195804Highwire
Oct 20198132Highwire
Nov 20197322Highwire
Dec 20196930Highwire
Jan 20207231Highwire
Feb 20207000Highwire
Mar 202010511Highwire
Apr 20207321Highwire
May 20209101Highwire
Jun 20208400Highwire
Jul 20206030Highwire
Aug 20205910Highwire
Sep 20209123Highwire
Oct 202080103Highwire
Nov 202010982Highwire
Dec 202012522Highwire
Jan 20219330Highwire
Feb 202111735Highwire
Mar 202112092Highwire
Apr 202115443Highwire
May 202113320Highwire
Jun 20218021Highwire
Jul 202112141Highwire
Aug 202117243Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me